TriSalus Life Sciences, Inc. (TLSI) — Stock Score Summary

TriSalus Life Sciences, Inc. (TLSI) has a MoatMap StockRank of 18/100 based on Quality (34/100), Value (48/100), and Momentum (22/100) factor scores. The current signal is STRONG SELL. TriSalus Life Sciences is an early-stage medical device and therapeutics company. It is unprofitable, highly speculative, and does not possess the established regulatory or manufacturing scale of a high-moat CDMO.

TriSalus Life Sciences, Inc. is a medical device company developing innovative drug delivery systems designed to improve outcomes for patients with solid tumors, particularly those resistant to conventional therapies. Its competitive moat is built on proprietary Pressure-Enabled Drug Delivery (PEDD) technology, which aims to overcome biological barriers and enhance targeted therapy penetration. TriSalus is positioned as a specialized innovator in interventional oncology, addressing critical unmet needs in cancer treatment.

Key Financial Metrics

Price$3.34
Market Cap$201M
P/E (Forward)-13.20
Price/Book-4.87
Return on Invested Capital-141.3%
Debt/Equity269.28
Gross Margin85.1%
Operating Margin-94.5%
Revenue Growth-2.9%
Free Cash Flow$-9M

TriSalus Life Sciences, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is TriSalus Life Sciences, Inc.’s (TLSI) StockRank?
MoatMap’s StockRank for TriSalus Life Sciences, Inc. (TLSI) is 18/100, with a Strong Sell signal. It is a composite of Quality (34), Value (48), and Momentum (22) factor ranks across MoatMap’s 19,000+ stock universe.
Does TriSalus Life Sciences, Inc. have an economic moat?
TriSalus Life Sciences, Inc. (TLSI) has a Quality factor score of 34/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is TriSalus Life Sciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for TriSalus Life Sciences, Inc. (TLSI) is Strong Sell, based on a StockRank of 18/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is TriSalus Life Sciences, Inc. in?
TriSalus Life Sciences, Inc. (TLSI) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksTLSI deep dive reportAI ChampionsHow we score stocksSense-check another stock